Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04460495 · ClinicalTrials.gov registry record · NA
Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04460495 is a NA study that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 8 participants.
The verdict
NCT04460495, a NA study, was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial looks to study the safety and feasibility of using oxygen-enhanced molecular MRI to understand how cancer cells use oxygen differently than normal cells. Cancer cells tend to utilize (or not utilize) oxygen differently than normal cells. By using the oxygen-enhanced molecular MRI, researchers will be able to create spatial "maps" depicting areas of abnormal oxygen utilization unique to cancer. This type of information may be useful for diagnosing new cancers, understanding various "subtypes" of cancer that might utilize oxygen differently, or this information may be useful for evaluating new drugs that impact cancer metabolism.
Interventions
- PROCEDURE Arterial Spin Labeling Magnetic Resonance Imaging
- PROCEDURE pH-Weighted amine CEST
- PROCEDURE Oxygen-weighted SAGE-EPI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2021-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04460495
The ClinicalTrials.gov registry entry for NCT04460495 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arterial Spin Labeling Magnetic Resonance Imaging is the first listed.
NCT04460495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04460495 about?
NCT04460495 is a clinical study titled "Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI". This trial looks to study the safety and feasibility of using oxygen-enhanced molecular MRI to understand how cancer cells use oxygen differently than normal cells. Cancer cells tend to utilize (or not utilize) oxygen differently than normal cells. By using the oxygen-enhanced molecular MRI, researc...
What is the current status of trial NCT04460495?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2020-07-07. Estimated completion is 2021-09-16.
What interventions are being tested in trial NCT04460495?
The interventions under investigation include: Arterial Spin Labeling Magnetic Resonance Imaging (PROCEDURE), pH-Weighted amine CEST (PROCEDURE), Oxygen-weighted SAGE-EPI (PROCEDURE).
Who is sponsoring clinical trial NCT04460495?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.